A Growth Vision
Amayeza confirms healthcare consolidation play through newly established Vertice Medtech Group
"We are excited to be partnering with Ethos
on this expansion vision and believe this transaction is a strong endorsement of the levels of service excellence that we have delivered to our stakeholders over many years.
Looking ahead, we shall make significant investment in capacitating Vertice Medtech – including bolstering leadership and new products – in order to deliver our growth vision. We shall also continue growing organically and via new distributions as illustrated by recently concluded agreements with Terumo IS for Cardiology, or Medela and Matriderm for SilvoCure.
We are highly confident that this long-term investment will benefit our stakeholders, employees and ultimately the patients we all serve." - Patrick Godard, Vertice Healthcare CEO